一、企业概况：

　　       山西康欣药业有限公司前身是文水县国营制药厂，建厂于１９７１年，２００１年改制为股份制企业，公司占地面积３万平方米，现有资产２４００万元，全公司职工１６０人，大中专以上学历５８人，占全体员工数３４．１％，其中高中级职称１２人，初级职称６５人，医药专业技术人员６２人。２００１年实现销售收入１２０６万元，实现利税１７１万元，２００２年实现销售收入１６５０万元，实现利税１７９万元。

　　二、项目概况：

　　       １、产品及规模：

　　       年产０．５ｇ／片的脑珍片３亿片。

　　       ２、原材料来源及市场分析：

　　       山西是中药材重点产地。中药材和辅料的供应充足。

　　       真菌类药品，能有效增强人体免疫力，能增强身体抵抗力，还是人们防病的良药，其市场前景看好，在日本已有用生物技术的方法生产人参和紫草的品种 并以保健品和化妆品推向市场，创造了较好的效益，故本品在东南亚及海外市场有很大的市场潜力。

　　       ３、项目建设地址及前期工作进展：

　　       项目建设地址为文水县县城，该项目已立项，准备前期工作。

　　       ４、项目总投资及资金来源：

　　       该项目总投资为５７００万元，拟用外资４８０万美元，折合人民币４０００万元。

　　       ５、合作方式：合资、合作。

　　       ６、项目经济效益预测：

　　       项目实施后，年销售收入２６７００万元，年利税总额５５８６万元，投资利润率６５．２９％，投资利税率１０２．５５％，投资回收３．６２期年。

　　三、联系方式：

　　       项目联系人：康富保

　　　　电话：０３５８－３０２２３３０　

　　　　传真：０３５８－３０２２３３０　

　　　　地址：文水县城

　　　　邮编：０３２１００

　　

　　

　　

　　

　　Ｔｒａｄｉｔｉｏｎａｌ Ｃｈｉｎｅｓｅ Ｍｅｄｉｃｉｎｅ

　　Ｐｒｏｃｅｓｓｉｎｇ Ｐｒｏｊｅｃｔ

　　Ｉ． Ｇｅｎｅｒａｌ Ｓｉｔｕａｔｉｏｎ ｏｆ Ｐｒｏｊｅｃｔ Ｕｎｉｔ

　　       Kangxin Pharmaceutical Co., Ltd of Shanxi was once a state-owned factory founded in 1971. It is reorganized as a joint-stock enterprise in 2001. It covers an area of 30,000 m with staff and workers 160 in which 58 are graduates from colleges and universities making up 34.1% of the total, those with middle and high title of technical post 12, primary 65 and technicians 62. The annual sales income in 2001 was 12,060,000 yuan, profit and tax 1,710,000

　　yuan. Those in 2002 was 16,500,000 yuan and 1,790,000 yuan respectively.

　　ＩＩ． Ｇｅｎｅｒａｌ Ｓｉｔｕａｔｉｏｎ ｏｆ Ｐｒｏｊｅｃｔ Ｕｎｉｔ

　　       1. Products and Scale

　　       To produce 300,000,000 Naozhen tablets (0.5g/tablet) yearly

　　       2. Raw Material and Marketing

　　       Shanxi is rich in Chinese medicine, and the raw and additional material can be sufficiently supplied. Fungus medicine can improve immunity of human beings and build up one's resistance to disease. It can also help in disease prevention. It will find a big market. In Japan, ginseng and Asian puccoon have been grown with biological technology. Its products as health protection goods and cosmetics are selling well. From the above, Naozhen tablets will find a big market in Southeast Asian and overseas markets.

　　       3. Location and Implementation in Earlier Stage

　　       It is located in Wenshui County. The project is approved and under preparation.

　　       4. Investment and Capital

　　       The total investment is 57,000,000 yuan in which 4,800,000 US dollars( 40,000,000 yuan) is to be introduced.

　　       5. Cooperation Mode

　　       Joint-venture or cooperation

　　       6. Benefit Analysis

　　       The annual sales income will be 267,000,000 yuan, the profit and tax 55,860,000 yuan, rate of profit 65.29%, rate of profit and tax 102.55%, investment recovery period 3.62 years

　　ＩＩＩ． Ｃｏｎｔａｃｔ Ｆｏｒｍ

　　       Contact Man: Kang Fubao

　　       Tel: 0358-3022330

　　       Fax: 0358-3022330

　　       Add: Wenshui County, Shanxi Province

　　       P.C: 032100